4//SEC Filing
Wynholds Kristin 4
Accession 0000899243-22-037418
CIK 0001832415other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:15 PM ET
Size
6.4 KB
Accession
0000899243-22-037418
Insider Transaction Report
Form 4
Wynholds Kristin
Chief Product Officer
Transactions
- Award
Common Stock
2022-05-31$1.54/sh+5,023$7,728→ 95,038 total - Award
Common Stock
2022-11-30$1.24/sh+3,781$4,692→ 98,819 total
Footnotes (1)
- [F1]These shares were acquired under the Better Therapeutics, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001889329
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:15 PM ET
- Size
- 6.4 KB